Trade Summary

2 months ago, Xia Yu, serving as Dir at Summit Therapeutics Inc. (SMMT), purchased 533,617 shares at $18.74 per share, for a total transaction value of $9,999,983.00. Following this transaction, Xia Yu now holds 32,057,147 shares of SMMT.

This purchase represents a 2.00% increase in Xia Yu's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, October 21, 2025 and publicly disclosed via SEC Form 4 filing on Thursday, October 23, 2025, 2 days after the trade was made.

Summit Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.